CompaniesProvenance Biopharmaceuticals

Provenance Biopharmaceuticals

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

0

As Collaborator

1

Total Enrollment

8

By Phase

PHASE1/PHASE2: 1

By Status

ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
NCT03958383
Hover over trial bars to see details

Recent Trials

NCT03958383Collaborator
IT-hu14.18-IL2 With Radiation, Nivolumab and Ipilimumab for Melanoma
PHASE1/PHASE2Active, not recruiting
8 participants
Started: Jan 30, 2020 · Completed: Aug 15, 2026